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L-Arginine Reduces the Increased Incidence of 
Ventricular Arrhythmias During Sympathetic 
Stimulation in Dogs with Acute Coronary Artery 
Occlusion
L. Fei, C. Arnett, D.P. Zipes. Krannert Institute of Cardiology, Indiana 
University Medical Center, Indianapolis, IN, USA
Nitric oxide (NO) modulates autonomic effects on mechanical and electro- 
physiologic function of the heart. Whether NO influences the prevalence of 
ventricular arrhythmias (VA) enhanced by sympathetic stimulation (SS) is 
unknown. We studied the influence of the NO precursor, L-arginine (LA), on 
the incidence of spontaneous VA during SS in 15 autonomlcally denervated 
dogs undergoing repeated 7 min occlusions of the left descending coronary 
artery. Bilateral SS (4 Hz, 4 ms, 4-15 volts) was delivered to decentralized 
stellate ganglia. The effects of LA (100 mM) were assessed by infusing the 
drug into the pericardial sac for 30 min where it superfused cardiac vagal 
and sympathetic nerves. The study protocol and results are shown in the 
figure. Seven dogs were eliminated because they had no VA during SS. 
The incidence of VA significantly increased during SS, while LA reduced this 
increase caused by SS. After washout of LA, the incidence of VA increased 
to the same degree as before pericardial superfusion with LA (p = 0.600).
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Conclusions: Intrapericardial LA reduces the increased incidence of ven­
tricular arrhythmias during SS in dogs with acute coronary occlusion, which 
may relate to LA-related modulation of sympathetic activity.
A Coronary Selective ATP-sensitive Potassium 
Channels Opener, JTV-506, Improves Myocardial 
Ischemia without Alteration of Systemic 
Hemodynamics in the Canine Hearts
H. Funaya, M. Kitakaze, H. Sato, M. Hori. The First Dept of Med., Osaka 
Univ., Osaka, Japan
ATP-sensitive K+ channels opener (KCO) mediates cardioprotective effects. 
However, an intravenous administration of KCO may acutely reduce aortic 
blood pressure, which blunts the cardioprotection of KCO activating sympa­
thetic tones and renin-angiotensin systems. Since experiments using coro­
nary vascular rings revealed that JTV-506, a new KCO, is coronary-selective, 
we tested If intravenous administration of JTV-506 mediates cardioprotec­
tion on ischemic hearts without alteration of systemic hemodynamics. In 20 
dogs, the left anterior descending coronary artery (LAD) was perfused with 
blood from the carotid artery. When we administered JTV-506 (1, 2, 4, 6 
and 8 jti g/kg) into the systemic vein, coronary blood flow (CBF) increased 
dose-dependently from 92 ±  1 to 110 ±  5 ml/100 g/min without reduction of 
aortic blood pressure (AoP: 107 i  2 and 102 ±  4 mmHg). When doses of 
JTV-506 Increased to 16 ¡ i g/kg, CBF decreased to 101 ±  3 ml/100 g/min with 
decreased AoP (87 =fc 5 mmHg). in the ischemic heart due to the constant 
reduction of coronary perfusion pressure (CPP: 52 i  5 mmHg), CBF (53 ± 
1 mi/100 g/min), fractional shortening (FS: 12 ±  1%) and lactate extraction 
ratio (LER: 0.3 ±  2.1%) decreased. JTV-506 of 4 /¿g/kg increased CBF from 
53 ±  1 to 74 ±  4 ml/100 g/mln, while CPP and AoP were unchanged (58 ± 3 
and 101 ±  3 mmHg). End/Epi flow ratio increased from 073 ±  0.05 to 0.84 
±  0.04, and FS (17 ±  2%), LER (16 ±  3%) and the pH in coronary venous 
blood (7.18 db 0.05 to 7.36 ±  0.02) were also increased. Norepinephrine, 
renin activity and angiotensin II concentration in the systemic venous blood 
was not increased due to 8 /¿g/kg JTV-506 (389 ±  146 vs. 182 ±  85 pmol/ml, 
11.1 ±  1.7 vs. 11.8 d= 1.3 ng/ml/min, 653 ± 1 7 6  vs. 565 ±  53 pg/ml). 
We conclude that JTV-506 can mediate the selective coronary vasodilation 
and improvements of myocardial ischemia without affecting systemic biood 
pressure, syrripathetictonesandrenin-angiotensin systems. This coronary se­
lective new ATP-sensitive K+ channel openers, JT-506, may be promising 
for the treatment of ischemic heart disease.
Co-Localization of C-Reactive Protein and
Complement in Human Hearts during Acute 
Myocardial infarction
W.K. Lagrand1, H.W.M. Niessen2, G.-J. Wolbink4, L.H. Jaspars2,
C.A. Visser1, F.W.A. Verheugt1, C.J.L.M. Meijer2, C.E. Hack34. 
v Department of Cardiology,2 Department of Pathology, 3 Department of 
Internal Medicine, Free University Hospital, Amsterdam, The Netherlands,
4 Central Laboratory of the Netherlands Red Cross Blood Transfusion 
Service, Amsterdam, The Netherlands
C-reactive protein (CRP) plasma levels correlate with clinical outcome in pa­
tients with myocardial ischemia and infarction. We hypothesized that these 
correlations might reflect active participation of CRP in the local inflamma­
tory response ensuing in the jeopardized myocardium, since upon binding 
to a ligand CRP is able to activate the classical pathway of complement. In 
addition, complement activation has been shown to occur locally in human 
infarcted myocardium. To verify our hypothesis, we investigated immuno- 
histochemical localization of CRP, in relation to deposition of complement, 
in tissue specimens of infarcted and normal heart tissues obtained from 17 
patients, who had died following acute myocardial infarction (AMI). CRP was 
found to be deposited only in infarcted regions and not in normal appearing 
areas of human myocardium, being co-iocalized with depositions of C4- and 
C3-activation fragments of the complement system. Deposition of CRP and 
complement in infarcted myocardium appeared to be time-dependent since it 
was found In all infarctions except for one of very short duration (<12 hours) 
and two of long duration (>1 year).
Conclusion: CRP may localize in infarcted human heart tissue. As CRP 
was found co-localized with complement, we suggest that this acute phase 
protein promotes local complement activation, and hence tissue damage in 
AMI.
Early Refractoriness of Platelet GPIIb-llla in 
Myocardial Infarction Survivors
P.J. Goldschmidt-Clermont, L.D. Coleman, P.F. Bray, R.S. BlumenthaL 
Johns Hopkins University, Baltimore, MD, USA
Aggregation of platelets is mediated by the binding of fibrinogen to the ac­
tivated conformation of integrin al lb-03 (GPilb-ilia) on the platelet surface. 
With time after exposure of normal platelets to a stimulus (TRAP, 50 j*M), 
platelets lose the capacity to bind fibrinogen (left panel). Others have shown 
that this refractoriness of GPIIb-llla is due to internalization of the recep­
tor and is associated with loss of platelet aggregability. Platelet aggregation 
within a coronary vessel corresponds to the triggering step in the devel­
opment of myocardial infarction (Ml). We hypothesized that In survivors of 
myocardial infarction, GPIIb-llla refractoriness might occur. To test this hy­
pothesis, we analyzed the platelets of 51 post-MI patients, 3 to 21 days after 
their events. Binding of fibrinogen to activated platelets ex vivo (1 ¿¿M ADP) 
was significantly reduced in patients studied 3 to 5 days compared to 10 to 
21 days post-MI (p = 0.003), and tn patients studied 6 to 9 days versus 10 lo 
21 days post-MI (p = 0.01) (right panel).
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Based on these data, it is tempting to speculate that platelets from 
survivors undergo a period of refractoriness that might play an important 
role in limiting the thrombotic process affecting the coronary vessels of these 
patients.
